BETA-BLOCKERS AT DIFFERENT STAGES OF CARDIOVASCULAR CONTINUUM
https://doi.org/10.18705/1607-419X-2014-20-4-249-253
Abstract
A review of the current literature data and clinical recommendations on the use of beta-blockers in complex therapy of cardiovascular diseases at different stages of the cardiovascular continuum
About the Authors
A. O. Nedoshivin
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Russian Federation
O. V. Orlova
Federal Almazov Medical Research Centre, St Petersburg
Russian Federation
Corresponding author: Federal Almazov Medical Research Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. E-mail: ms_olgavla@mail.ru (Olga V. Orlova, PhD, Researcher at the Research Department of Preventive Cardiology).
Russian Federation
Corresponding author: Federal Almazov Medical Research Centre, 2 Akkuratov st., St Petersburg, Russia, 197341. E-mail: ms_olgavla@mail.ru (Olga V. Orlova, PhD, Researcher at the Research Department of Preventive Cardiology).
References
1. ESH/ESC Guidelines for the management of arterial hypertension // Eur. Heart J. — 2013. — Vol. 34, № 28. — P. 2159–2219.
2. ESC guidelines on the management of stable coronary artery disease // Eur. Heart J. — 2013. — Vol. 34, № 38. — P. 2949–3003.
3. Olsson G., Rehnqvist N., Sjogren A. et al. Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidity // J. Am. Coll. Cardiol. — 1985. — Vol. 5, № 6. — P. 1428–1437.
4. Yusuf S., Wittes J., Friedman L. Overview of results of randomized clinical trials in heart disease // J. Am. Med. Assoc. — 1988. — Vol. 260, № 14. — P. 2088–2093.
5. Narins C., Zareba W., Moss A. et al. Relationship between intermittent claudication, infl ammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction // Arch. ntern. Med. — 2004. — Vol. 164, № 4. — P. 440–446.
6. Bangalore S., Steg G., Deedwania P. et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease // J. Am. Med. Assoc. — 2012. — Vol. 308, № 13. — P. 1340–1349.
7. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр) // Сердечная недостаточность. — 2013. — Т. 14, № 7. — C. 379–472. / National guidelines of the Society of the Specialists of Heart Failure, Russian Society of Cardiology and Russian Scientifi c and Medical Society of Physicians on diagnostics and management of chronic heart failure (4 reappraisal) // Heart Failure [Serdechnaja Nedostatochnost]. — 2013. — Vol. 14, № 7. — P. 379–472 [Russian].
8. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) // Lancet. — 1999. — Vol. 353, № 12. — P. 2001–2007.
Review
For citations:
Nedoshivin A.O., Orlova O.V. BETA-BLOCKERS AT DIFFERENT STAGES OF CARDIOVASCULAR CONTINUUM. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2014;20(4):249-253. (In Russ.) https://doi.org/10.18705/1607-419X-2014-20-4-249-253
Views:
907
Email this article 